Overall, these lines of evidence suggest the ability of MitoTEMPO to prevent retinal degeneration and photoreceptor ferroptosis in mice with impaired atRAL clearance through inhibiting the activation of the KEAP1/NRF2/HO-1 signaling pathway. Here, HMOX1 is linked to retinal degeneration.